Drugs for Diabetes Insipidus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 110)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Tolvaptan |
Approved |
Phase 4 |
|
150683-30-0 |
216237 |
Synonyms:
JINARC
JYNARQUE
OPC-41061
OPC-41061(TOLVAPTAN)
|
OPC-41061|Samsca®
SAMSCA
TOLVAPTAN
|
|
2 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
3 |
|
Exenatide |
Approved, Investigational |
Phase 4 |
|
141758-74-9 |
45588096 |
Synonyms:
AC 2993
AC002993
AC-002993
AC2993
AC-2993
AC2993A
AC-2993A
AC-2993LAR
BYDUREON
BYDUREON BCISE
BYDUREON PEN
|
BYETTA
DA-3091
Exenatida
EXENATIDE
EXENATIDE SYNTHETIC
Exendin 4
EXENDIN-4
ITCA-650
LY2148568
LY-2148568
SYNTHETIC EXENDIN-4
|
|
4 |
|
Hydrocortisone succinate |
Approved |
Phase 4 |
|
2203-97-6 |
3643 |
Synonyms:
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethoxy)-4-oxobutanoate
Cortisol 21-(hydrogen succinate)
Cortisol succinate
HYDROCORTISONE HEMISUCCINATE
|
Hydrocortisone hemisuccinate anhydrous
Hydrocortisone hydrogen succinate
HYDROCORTISONE SUCCINATE
Hydroxycortisone succinate
NSC-7576
|
|
5 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 4 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
BARQUINOL HC
CHLOROMYCETIN HYDROCORT
COLIFOAM
CORTEF ACETATE
CORTIFOAM
Cortisol 21-acetate
CORTRIL
CORTUCID
DRICORT
EPIFOAM
FRAMYCORT
FUCIDIN H
GENTICIN HC
GENTISONE HC
|
GPPE EAR SUSP
GPPE EYE CRM
GPPE FOAM AERO
HC45 HYDROCORT
HEMSOL-HC
HEPACORT PLUS
HYDROCAL
HYDROCORTISONE 21-ACETATE
HYDROCORTISONE ACETATE
HYDROCORTONE
LANACORT
MICORT-HC
NEO-CORTEF
NSC-741
ORABASE HCA
|
|
6 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 4 |
|
50-23-7 |
3640 5754 |
Synonyms:
(11ALPHA,14BETA)-11,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11Β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(1S,2R,10S,11S,14S,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11Β,17α,21-trihydroxy-4-pregnene-3,20-dione
11Β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
ACETASOL HC
ACTICO МИХАИЛRT
Acticort
Acticort®|Efmody®|Plenadren®
Aeroseb HC
Aeroseb-HC
Alacort
Ala-cort
Ala-scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort-HC
ANUGESIC HC
Anusol HC
ANUSOL PLUS HC
ANUSOL SOOTHING RELIEF
Anusol-HC
Aquacort
Aquanil HC
Balneol-HC
Barseb HC
Basan-corti
Beta-HC
b-HC
CaldeCORT spray
CALMURID HC
CANESTEN HC
Cetacort
Chronocort
CIPRO HC
Clear aid
Cleiton
Cobadex
Colocort
Compound F
CORLAN
Cor-oticin
Cortanal
Cor-tar-quin
Cort-dome
Cortef
CORTENEM
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisolonum
Cortisporin
Cortisporin otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
CORTRIL
Cremesone
Cremicort-H
Cutisol
DAKTACORT
DAKTACORT HYDROCORT
Delacort
DERMA CARE HYDROCORT
Dermacort
Derm-aid
DERMASPRAY DEMANG
Dermil
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
ECONACORT
Ef corlin
Efcorbin
Efcortelan
EFCORTELAN P
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EURAX-HC
EURAX-HYDROCORT
Evacort
EXE-CORT
Ficortril
Fiocortril
Flexicort
Foille insetti
Genacort
GERMOLOIDS HC
Glycort
GREGODERM
gyno-Cortisone
HC
|
HC #1
HC #4
HC (HYDROCORTISONE)
HC45
H-Cort
Heb cort
Heb-cort
Hi-cor
Hidalone
hidro-Colisona
Hidrocortisona
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
hydro-Colisona
Hydrocort
HYDROCORT IN CALAMINE OILY
HYDROCORT IN CETOMACROGOL FOR A
HYDROCORT IN WTE SOFT PARAF
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
Hydrocortisone sodium phosphate
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisonum
Hydrocortistab
Hydrocortisyl
HYDROCORTONE
HYDRODERM
HYDRODERM HC
hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone lotion
Idrocortisone
Incortin-H
Incortin-hydrogen
JUNGLE FOR
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
Locoid
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
MILDISON LIPOCREAM
Milliderm
neo-Cort-dome
neo-Cortef
Neosporin-H ear
Nogenic HC
NSC-10483
Nutracort
NYBADEX
Nystaform-HC
Ophthocort
Optef
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
OTOSEPTIL
Otosone-F
OTOSPORIN
Pediotic suspension
Penecort
PERINAL
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Prepcort
Prestwick_265
Prevex HC
Proctocort
PROCTOCREAM HC
Proctofoam
PROCTOFOAM HC
PROCTOSEDYL
Protocort
QUINOCORT
Racet
Rectoid
Reichstein's substance m
Remederm HC
Sanatison
Scalpicin capilar
Schericur
Scheroson F
SENTIAL HC
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Tarcortin
Terra-cortril
TERRA-CORTRIL NYSTATIN
Texacort
Timocort
TIMODINE
Topicort
TOPISONE
Transderma H
Traumaide
TRI-CICATRIN
U-cort
Uniderm
UNIROID
UNIROID HC
Vioform-hydrocortisone
VoSol HC
Vytone
XYLOPROCT
Zenoxone
β-HC
|
|
7 |
|
Lithium carbonate |
Approved |
Phase 4 |
|
554-13-2 |
|
Synonyms:
CAMCOLIT 250
CAMCOLIT 400
Carbonic acid, dilithium salt
CP-1546761
CP-15467-61
Dilithium carbonate
ESKALITH
ESKALITH CR
LISKONUM
|
LITHANE
Lithii carbonas
LITHIUM CARBONATE
LITHOBID
LITHONATE
LITHOTABS
NSC-16895
PHASAL
|
|
8 |
|
Amiloride |
Approved |
Phase 4 |
|
17440-83-4, 2016-88-8, 2609-46-3 |
16231 |
Synonyms:
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
Alphapharm brand OF amiloride hydrochloride
Amiclaran
Amidal
Amiduret trom
AMILAMONT
Amiloberag
Amilorid
Amilorida
Amilorida [INN-Spanish]
Amiloride
AMILORIDE HCL
amiloride HCl|Midamor®
Amiloride hydrochloride
AMILORIDE HYDROCHLORIDE DIHYDRATE
Amiloride hydrochloride hydrate
Amiloride hydrochloride, anhydrous
Amiloridum
Amiloridum [INN-Latin]
AMILOSPARE 5
Amipramidin
Amipramidine
Amipramizid
Amipramizide
|
Amiprazidine
AMORIDE
AMR
Amrad brand OF amiloride hydrochloride
Amyloride
Anhydrous amiloride hydrochloride
BERKAMIL
Berolina brand OF amiloride hydrochloride
Cahill may roberts brand OF amiloride hydrochloride
Douglas brand OF amiloride hydrochloride
Guanamprazin
Guanamprazine
Hydrochloride, amiloride
Hydrochloride, anhydrous amiloride
HYDRO-RIDE
Kaluril
Merck brand OF amiloride hydrochloride
Merck sharp and dohme brand OF amiloride hydrochloride
Midamor
Midoride
Modamide
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
Trom, amiduret
Trommsdorff brand OF amiloride hydrochloride
|
|
9 |
|
Hemostatics |
|
Phase 4 |
|
|
|
10 |
|
Deamino Arginine Vasopressin |
|
Phase 4 |
|
|
|
11 |
|
Coagulants |
|
Phase 4 |
|
|
|
12 |
|
Hormones |
|
Phase 4 |
|
|
|
13 |
|
Vasoconstrictor Agents |
|
Phase 4 |
|
|
|
14 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
15 |
|
Anesthetics |
|
Phase 4 |
|
|
|
16 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
17 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
18 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
19 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
20 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
21 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
22 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
23 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
24 |
|
Glucagon-Like Peptide 1 |
|
Phase 4 |
|
|
|
25 |
|
Incretins |
|
Phase 4 |
|
|
|
26 |
|
Anti-Obesity Agents |
|
Phase 4 |
|
|
|
27 |
|
Corticotropin-Releasing Hormone |
|
Phase 4 |
|
|
|
28 |
|
Hydrocortisone 17-butyrate 21-propionate |
|
Phase 4 |
|
|
|
29 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
30 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
31 |
|
diuretics |
|
Phase 4 |
|
|
|
32 |
|
Satavaptan |
Investigational |
Phase 3 |
|
185913-78-4 |
158348 |
Synonyms:
[<sup>3</sup>H]-SR121463A
1-(4-(N-Tert-butylcarbamoyl)-2-methoxybenzenesulfonyl)-5-ethoxy-3-spiro-(4-(2-morpholinoethoxy)cyclohexane)indol-2-one fumarate
1-(4-(N-Tert-butylcarbamoyl)-2-methoxybenzenesulfonyl)-5-ethoxy-3-spiro(4-(2-morpholinoethoxy)cyclohexane)indoline-2-one, phosphate monohydrate cis-isomer
AQUILDA
N-Tert-butyl-4-({5'-ethoxy-4-[2-(morpholin-4-yl)ethoxy]-2'-oxo-1',2'-dihydrospiro[cyclohexane-1,3'-indole]-1'-yl}sulfonyl)-3-methoxybenzene-1-carboximidate
N-Tert-butyl-4-({5'-ethoxy-4-[2-(morpholin-4-yl)ethoxy]-2'-oxo-1',2'-dihydrospiro[cyclohexane-1,3'-indole]-1'-yl}sulphonyl)-3-methoxybenzene-1-carboximidate
N-Tert-butyl-4-({5'-ethoxy-4-[2-(morpholin-4-yl)ethoxy]-2'-oxo-1',2'-dihydrospiro[cyclohexane-1,3'-indole]-1'-yl}sulphonyl)-3-methoxybenzene-1-carboximidic acid
|
SATAVAPTAN
SR 121463
SR 121463A|SR-121463B|SR-121463F|SR121463A
SR-121463
SR-121463A
SR-121463B
SR-121463F
|
|
33 |
|
Atorvastatin |
Approved |
Phase 2 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-FLUOROPHENYL)-3-PHENYL-4-(PHENYLCARBAMOYL)-5-(PROPAN-2-YL)-1H-PYRROL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
ATORVASTATIN
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
Atorvastatina
Atorvastatine
Atorvastatinum
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
|
Cardyl
Faboxim
Hipolixan
Hydrate, atorvastatin calcium
LCF872
Lipitor
Lipitor®
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
Normalip
PREVENCOR
Sincol
Sortis
Sotis
TAHOR
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
Vastina
Xanator
Xarator
Xavator
ZARATOR
Zurinel
|
|
34 |
|
Benzocaine |
Approved, Investigational |
Phase 2 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
35 |
|
Tannic acid |
Approved |
Phase 2 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
36 |
|
Dulaglutide |
Approved, Investigational |
Phase 2 |
|
923950-08-7 |
|
Synonyms:
Dulaglutida
DULAGLUTIDE
LY2189265
|
|
|
37 |
|
Hypoglycemic Agents |
|
Phase 2 |
|
|
|
38 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
39 |
|
Hypolipidemic Agents |
|
Phase 2 |
|
|
|
40 |
|
Anticholesteremic Agents |
|
Phase 2 |
|
|
|
41 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
42 |
|
Lipid Regulating Agents |
|
Phase 2 |
|
|
|
43 |
|
Metformin |
Approved |
Phase 1 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
44 |
|
Chlorpropamide |
Approved, Investigational |
|
|
94-20-2 |
2727 |
Synonyms:
1-(p-Chlorobenzenesulfonyl)-3-propylurea
1-(p-Chlorobenzenesulphonyl)-3-propylurea
1-(p-Chlorophenylsulfonyl)-3-propylurea
1-(p-Chlorophenylsulphonyl)-3-propylurea
1-Propyl-3-(p-chlorobenzenesulfonyl)urea
1-Propyl-3-(p-chlorobenzenesulphonyl)urea
4-Chloro-N-((propylamino)carbonyl)benzenesulfonamide
4-Chloro-N-((propylamino)carbonyl)benzenesulphonamide
4-Chloro-N-[(propylamino)carbonyl]benzenesulfonamide
4-Chloro-N-[(propylamino)carbonyl]benzenesulphonamide
Adiaben
Apo-chlorpropamide
Apotex brand OF chlorpropamide
Asucrol
Byk gulden brand OF chlorpropamide
Catanil
Chlorodiabina
Chloronase
Chloropropamide
Chlorporpamide
CHLORPROPAMID
CHLORPROPAMIDE
Chlorpropamide Bp/ Usp
Chlorpropamidum
Clorpropamid
Clorpropamida
Clorpropamide
Diabaril
Diabechlor
DIABEMIDE
Diabenal
|
DIABENESE
Diabenese®|Glucamide®
Diabeneza
Diabetoral
Diabet-Pages
Diabinese
Diamel Ex
Dynalase
Farmasierra brand OF chlorpropamide
Glisema
Glucamide
GLYMESE
Insogen
Insulase
Meldian
MELITASE
Mellinese
Millinese
N-(4-Chlorophenylsulfonyl)-n'-propylurea
N-(4-Chlorophenylsulphonyl)-n'-propylurea
N-(p-Chlorobenzenesulfonyl)-n'-propylurea
N-(p-Chlorobenzenesulphonyl)-n'-propylurea
Novo-Propamide
N-Propyl-n'-(p-chlorobenzenesulfonyl)urea
N-Propyl-n'-(p-chlorobenzenesulphonyl)urea
N-Propyl-n'-p-chlorophenylsulfonylcarbamide
N-Propyl-n'-p-chlorophenylsulphonylcarbamide
Oradian
Pfizer brand OF chlorpropamide
Stabinol
|
|
45 |
|
Indomethacin |
Approved, Investigational |
|
|
53-86-1 |
3715 |
Synonyms:
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
Aconip
Amuno
Apo-Indomethacin
Argun
Arthrexin
ARTRACIN
ARTRACIN SR
Artrinovo
Artrivia
BERLIND 75 RET
Bonidin
Bonidon
Bonidon Gel
Catlep
Chibro-Amuno
Chrono-Indicid
Chrono-Indocid
Confortid
Dolcidium
Dolcidium Pl
Dolovin
Durametacin
Elmetacin
Flexin Continus
FLEXIN-25 CONTINUS
FLEXIN-50 CONTINUS
FLEXIN-75 CONTINUS
Hicin
Hydrochloride, indomethacin
Idomethine
IMBRILON
IMN
Inacid
Indacin
Indaflex
Indameth
Indmethacine
Indocid
Indocid Pda
INDOCID RET
Indocid Sr
Indocid®|Indocin®
INDOCID-R
Indocin
Indocin I.V
Indocin I.V.
INDOCIN SR
INDODERM
INDOFLEX
INDOLAR
INDOLAR SR
INDO-LEMMON
INDOMAX-25
INDOMAX-75 SR
Indomecol
|
Indomed
Indomee
Indomet 140
Indometacin
INDOMETACIN FARNESIL
Indometacina
Indometacine
Indometacinum
Indometacyna
INDOMETHACIN
Indomethacin hydrochloride
Indomethacine
Indomethacinum
Indomethancin
Indomethazine
Indomethegan
Indomethine
Indometicina
Indomo
INDOMOD
INDO-PAED
Indo-Phlogont
Indoptic
INDOPTOL
Indo-Rectolmin
Indorektal
Indo-Spray
Indo-Tablinen
INDOTARD MR 75
Indoxen
Inflazon
Infrocin
Inteban Sp
Lausit
LEDMECIN
Liometacen
MAXIMET SR
Metacen
Metartril
Methazine
Metindol
Miametan
Mikametan
MOBILAN
Novomethacin
Novo-Methacin
NSC-77541
Nu-Indo
Osmosin
PARDELPRIN MR
Reumacide
Rhemacin La
RHEUMACIN LA
RIMACID
Sadoreum
SLO-INDO
Tannex
TIVORBEX
Vonum
|
|
46 |
|
Sodium citrate |
Approved, Investigational |
|
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
47 |
|
Hydrochlorothiazide |
Approved, Vet_approved |
|
|
58-93-5 |
3639 |
Synonyms:
3,4-Dihydrochlorothiazide
6-CHLORO-1,1-DIOXO-3,4-DIHYDRO-2H-1$L^{6},2,4-BENZOTHIADIAZINE-7-SULFONAMIDE
Acuretic
Aldactazide
Aldoril
APO-HYDRO
Apo-hydro®
Apresazide
Aquarills
Aquarius
Bremil
Caplaril
Capozide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Cidrex
COTAREG
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Diu-Melusin
Diuril
Drenol
Dyazide
ESI879
Esidrex
Esidrix
ESIDRIX (TN)
Esimil
Fluvin
HCT
HCTZ
HCZ
Hidril
Hidrochlortiazid
Hidroclorotiazida
Hidroronol
Hidrotiazida
Hydril
|
Hydro-aquil
Hydrochloro thiazide
Hydrochlorothiazid
HYDROCHLOROTHIAZIDE
Hydrochlorothiazide intensol
Hydrochlorothiazidum
Hydrochlorthiazide
Hydro-D
Hydrodiuretic
Hydrodiuril
Hydro-diuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hypothiazid
Hypothiazide
Hyzaar
Idrotiazide
Inderide
Ivaugan
Jen-diril
Lopressor HCT
Lotensin HCT
Maschitt
Maxzide
Megadiuril
Microzide
Moduretic
Nefrix
Neo-codema
Neoflumen
Newtolide
NSC-53477
Oretic
Panurin
Prinzide
Ro-hydrazide
Sectrazide
Ser-ap-es
Servithiazid
SU-5879
Thiaretic
Thiuretic
Thlaretic
Timolide
Unipres
Urodiazin
Vaseretic
Vetidrex
Ziac
Zide
|
|
48 |
|
Sildenafil |
Approved, Investigational |
|
|
139755-83-2, 171599-83-0 |
5212 135398744 |
Synonyms:
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulphonyl)-4-methylpiperazine
1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
1-{[3-(4,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-ETHOXYPHENYL]SULFONYL}-4-METHYLPIPERAZINE
5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE
5-[2-ETHOXY-5-(4-METHYL-PIPERAZINE-1-SULFONYL)-PHENYL]-1-METHYL-3-PROPYL-1,6-DIHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE
Acetildenafil
Aphrodil
Caverta
Citrate, sildenafil
Desmethyl sildenafil
Desmethylsildenafil
HIP0908
HIP-0908
Homosildenafil
Hydroxyhomosildenafil
Lactate, sildenafil
NCX 911
|
NCX-911
NIPATRA
Nitrate, sildenafil
Revatio
Sildenafil
Sildenafil citrate
Sildenafil lactate
Sildenafil nitrate
Sildenafil Viagra
Sildenafil, desmethyl
Sildenafilo
UK-92480
UK-9248010
UK-92480-10
Viagra
Viagra®
VIZARSIN
|
|
49 |
|
Salmon calcitonin |
Approved, Investigational |
|
|
47931-85-1 |
155817456 |
Synonyms:
CALCITONIN (SALMON SYNTHETIC)
Calcitonin salmon
CALCITONIN SALMON RECOMBINANT
Calcitonin, salmon
Calcitonina salmón sintética
|
Calcitonin-salmon
CT (salmon)|Miacalcin®
FORTICAL
Recombinant salmon calcitonin
Salmon calcitonin
|
|
50 |
|
Chlorothiazide |
Approved, Vet_approved |
|
|
58-94-6 |
2720 |
Synonyms:
6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonate amide
6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulphonate amide
6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulphonic acid amide
6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
6-Chloro-7-sulphamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
Aldoclor
Alurene
Azide
Chloriazid
Chlorosal
Chlorothiazid
Chlorothiazide
Chlorothiazidum
Chlorthiazide
Chlortiazid
Chlorurit
Chlotride
Chlrosal
Clorotiazida
Clotride
Diupres
Diuresal
Diuril
Diuril Boluses
|
Diuril®
Diurilix
Diurite
Diutrid
Esidrix
Flumen
Hydro-D
Hydrodiuril
MECHLOZID
Microzide
Minzil
Neo-Dema
NSC-25693
Oretic
Salisan
Salunil
Saluretil
SALURIC
Sk-Chlorothiazide
Thiazide
Urinex
UROFLUX
Warduzide
Yadalan
Zide
|
|
Interventional clinical trials:
(show top 50)
(show all 81)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
1-deamino 8-d-arginine Vasopressin in Percutaneous Ultrasound-guided Renal Biopsy: a Randomized Controlled Trial |
Completed |
NCT00748072 |
Phase 4 |
DDAVP;saline solution |
2 |
Tolvaptan Treatment to Reverse Worsening Outpatient Heart Failure: Possible Role of Copeptin In Identifying Responders (TROUPER) |
Completed |
NCT02476409 |
Phase 4 |
tolvaptan |
3 |
Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure |
Completed |
NCT01346072 |
Phase 4 |
tolvaptan |
4 |
The Effect of Midazolam Premedication on Copeptine Concentration in Blood |
Completed |
NCT03474939 |
Phase 4 |
Midazolam Oral Tablet |
5 |
Identification and Clinical Relevance of an Oxytocin Deficient State: a Randomized, Crossover, Placebo-controlled, Proof-of-concept, Physiopathological Study (GLP1 Study) |
Recruiting |
NCT04897802 |
Phase 4 |
Experimental: GLP1-RA (exenatide) administration;Control: Placebo administration |
6 |
Identification and Clinical Relevance of an Oxytocin Deficient State: a Randomized, Crossover, Placebo-controlled, Proof-of-concept Physiopathological Study (CRH Study) |
Recruiting |
NCT04902235 |
Phase 4 |
Experimental: CRH administration;Control: Placebo administration |
7 |
AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium: a Randomized Controlled Trial |
Not yet recruiting |
NCT05044611 |
Phase 4 |
Anhydrous Amiloride Hydrochloride;Placebo |
8 |
Acute Heart Failure With High Copeptin Levels Treated With Tolvaptan Targets Increased AVP Activation for Treatment Efficacy |
Unknown status |
NCT01733134 |
Phase 3 |
Tolvaptan;placebo |
9 |
Peroral Administration of Different Doses of Desmopressin Administered as a New Orally-Disintegrating Tablet and Desmopressin for Nasal Administration in the Treatment of CDI in Japanese Patients |
Completed |
NCT01280188 |
Phase 3 |
Desmopressin Oral Melt;Desmopressin intranasal |
10 |
A Multicenter, Uncontrolled, Open-label, Dose-titration Trial to Investigate the Efficacy and Safety of Tolvaptan Tablets in Patients With Hyponatremia in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) |
Completed |
NCT03048747 |
Phase 3 |
Tolvaptan Oral Tablet |
11 |
A Randomized, Double-Blind, Placebo-Group, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
Completed |
NCT00264927 |
Phase 3 |
SR121463B |
12 |
An Open-Label, Multicenter Study Evaluating the Long-Term Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
Completed |
NCT00264914 |
Phase 3 |
SR121463B |
13 |
Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial |
Completed |
NCT02967653 |
Phase 2 |
Atorvastatin |
14 |
A Phase 1b, Multicenter, Pilot, Randomized, Double-blind Trial to Determine the Pharmacokinetics and Pharmacodynamics of Orally Administered Tolvaptan 3.75, 7.5, and 15 mg Tablets in Subjects With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
Completed |
NCT02009878 |
Phase 1, Phase 2 |
tolvaptan |
15 |
Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia: "The GOLD-Study" |
Completed |
NCT02770885 |
Phase 2 |
Dulaglutide;Placebo |
16 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion. |
Completed |
NCT00032734 |
Phase 2 |
satavaptan (SR121463B) |
17 |
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock |
Completed |
NCT01611935 |
Phase 2 |
Vasopressin |
18 |
A Multi-center, Open-Label, Exploratory Study to Assess the Efficacy of PB in Decreasing the Urine Output and Increasing the Urine Osmolality in Patients With Hereditary Nephrogenic Diabetes Insipidus, Patients With Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan, And Severely Polyuric Patients With Previous Lithium Administration (Serendipity-PB1) |
Recruiting |
NCT05190744 |
Phase 2 |
PB |
19 |
Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot Study |
Not yet recruiting |
NCT04789148 |
Phase 1 |
Oxytocin nasal spray |
20 |
Use of Metformin to Treat Patients With Congenital Nephrogenic Diabetes Insipidus (NDI) |
Terminated |
NCT02460354 |
Phase 1 |
Metformin |
21 |
Study of Novel Types of Familial Diabetes Insipidus |
Unknown status |
NCT00004364 |
|
desmopressin |
22 |
Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery |
Unknown status |
NCT02687776 |
|
|
23 |
Study of Prognostic Value of Copeptin for Myocardial Infarct Size and 6-month Prognosis in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: GOOD I Study |
Unknown status |
NCT03074214 |
|
|
24 |
Evaluation of Copeptin in Patients With Cirrhosis and Ascites |
Unknown status |
NCT03318601 |
|
|
25 |
Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of Non-ST-Elevation Acute Coronary Syndromes - The COPACS Study |
Unknown status |
NCT01962506 |
|
|
26 |
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus |
Completed |
NCT00004363 |
|
chlorpropamide;desmopressin |
27 |
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus |
Completed |
NCT00478335 |
|
sildenafil;calcitonin;hydrochlorothiazide/amiloride;indomethacin;Placebo for sildenafil;placebo for calcitonin |
28 |
Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery |
Completed |
NCT04369703 |
|
|
29 |
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus |
Completed |
NCT00004360 |
|
chlorothiazide |
30 |
Copeptin After a Subcutaneous Stimulation With Glucagon in Adults (Healthy Volunteers and Patients With Diabetes Insipidus or Primary Polydipsia) - The Glucacop-Study |
Completed |
NCT04550520 |
|
|
31 |
Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study |
Completed |
NCT00757276 |
|
|
32 |
Use of Copeptin in the Differential Diagnosis of Diabetes insipidus-a Prospective International Study |
Completed |
NCT01940614 |
|
|
33 |
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls |
Completed |
NCT04648137 |
|
|
34 |
Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study |
Completed |
NCT03572166 |
|
|
35 |
Peer Support to Enhance Diabetes Shared Medical Appointments: Examining Comparative Effectiveness in VA Health Systems |
Completed |
NCT02132676 |
|
|
36 |
Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy |
Completed |
NCT02523001 |
|
|
37 |
Tracking Neurodegeneration in Early Wolfram Syndrome |
Completed |
NCT02455414 |
|
|
38 |
Fetal Copeptin After Oxytocin Challenge Test |
Completed |
NCT01962701 |
|
|
39 |
Copeptin During a Standardized Psychological Stress Test |
Completed |
NCT01866137 |
|
|
40 |
Prognostic Value of Copeptin Level Before Cardiac Surgery and Involvement in Systemic Inflammatory Response Syndrome After Cardiopulmonary Bypass |
Completed |
NCT03288610 |
|
|
41 |
Copeptin as a Novel Diagnostic and Prognostic Marker in the Management of Neurological and Neurosurgical Patients With Sodium Imbalance The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment) |
Completed |
NCT00390962 |
|
|
42 |
Kinetics of Copeptin in Healthy Volunteers - a Prospective International Study |
Completed |
NCT02647736 |
|
|
43 |
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders |
Completed |
NCT02626832 |
|
|
44 |
Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic Shock |
Completed |
NCT00698048 |
|
|
45 |
Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy |
Completed |
NCT03912766 |
|
|
46 |
Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers - The Macicop-Study |
Completed |
NCT03844217 |
|
Macimorelin 0.5mg/kg body weight;Macimorelin 0.75mg/kg body weight |
47 |
The Circadian Rhythm of Copeptin |
Completed |
NCT02604875 |
|
|
48 |
Proadrenomedullin and Copeptin as Predictors of Vasopressor Requirements and Volume Resuscitation in Patients With Septic Shock |
Completed |
NCT03104933 |
|
|
49 |
The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption - a Pathophysiological Study |
Completed |
NCT03883503 |
|
|
50 |
Evaluation of Serum Copeptin and Psychological Stress Level Among Healthcare Providers During COVID-19 Pandemic |
Completed |
NCT04757285 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
desmopressin
Desmopressin Acetate
|
Vasopressin (USP)
VASOPRESSIN TANNATE (IN OIL)
|
|